IPO Listing Status of Exxaro Tiles:
The shares of Exxaro Tiles debuted at a 10% premium on the bourses at Rs. 126. Exxaro Tiles’ initial public offering (IPO), which produces double charge vitrified tiles and glazed vitrified tiles, received a strong reaction from investors, with the issue being subscribed 22.68 times between August 4-6. In response to a 1.14 crore equity share offer, the company received bids for 25.96 crore equity shares.
The net proceeds from the new issue will be used to pay down debts and meet working capital needs.
IPO Listing Status of Devyani International:
Devyani International, the parent company of KFC, Pizza Hut, and Costa Coffee, had a strong launch on August 16 by listing at Rs. 141, at a 56% premium. It started trading at Rs 141 on the BSE and Rs 140.90 on the NSE, against an issue price of Rs 90 per share.
On August 4, the firm opened its Rs 1,838 crore initial public offering for subscription, which concluded on August 6 with a phenomenal 116.71 times subscription, generating bids for 1,313.79 crore equity shares against an offer size of 11.25 crore equity shares. Qualified institutional investors’ piece was subscribed 95.25 times, non-institutional investors’ portion was subscribed 213.06 times, retail investors’ portion was booked 39.52 times, and employees’ reserved portion was purchased 4.7 times.
The offer included a Rs 440 crore new issue and a Rs 1,398 crore offer for sale by investor Dunearn Investments and promoter RJ Corp. The proceeds from the new issue will be used to repay the company’s debts as well as for general business objectives.
IPO Listing Status of Windlas Biotech:
On August 16, Windlas Biotech was listed at Rs 439 on the BSE at a 4.6% discount. The company is one of the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization industry in terms of revenue.
The stock started the day at Rs 439 on the BSE and Rs 437 on the NSE. The pharma firm raised Rs 401.53 crore in a public offering that was oversubscribed by 22.47 percent from August 4-6 due to significant investor demand.
Qualified institutional purchasers’ share was subscribed 24.4 times, non-institutional investors’ portion was subscribed 15.73 times, and the retail component was subscribed 24.27 times.
The IPO included a fresh issue of Rs 165 crore and an offer for sale of Rs 236.53 crore by Vimla Windlass and Tano India Private Equity Fund II, with a price band of Rs 448-460 per equity share.
The company will use the net fresh issue proceeds to purchase equipment for capacity expansion of the existing facility at Dehradun Plant – IV and addition of injectables dosage capability at the existing facility at Dehradun Plant-II, as well as for incremental working capital requirements and debt repayment.
